These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17893252)

  • 21. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortistatin and pituitary hormone secretion in rat.
    Baranowska B; Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L
    J Physiol Pharmacol; 2009 Mar; 60(1):151-6. PubMed ID: 19439817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free fatty acids exert an inhibitory effect on adrenocorticotropin and cortisol secretion in humans.
    Lanfranco F; Giordano R; Pellegrino M; Gianotti L; Ramunni J; Picu A; Baldi M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1385-90. PubMed ID: 15001638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa.
    Lanfranco F; Gianotti L; Picu A; Giordano R; Daga GA; Mondelli V; Malfi G; Fassino S; Ghigo E; Arvat E
    Eur J Endocrinol; 2006 May; 154(5):731-8. PubMed ID: 16645021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary.
    Engler D; Pham T; Liu JP; Fullerton MJ; Clarke IJ; Funder JW
    Endocrinology; 1990 Oct; 127(4):1956-66. PubMed ID: 1976094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
    Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
    J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of protracted treatment with rosiglitazone, a PPARgamma agonist, in patients with Cushing's disease.
    Pecori Giraldi F; Scaroni C; Arvat E; Martin M; Giordano R; Albiger N; Leao AA; Picu A; Mantero F; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):219-24. PubMed ID: 16430724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.
    Castillo V; Theodoropoulou M; Stalla J; Gallelli MF; Cabrera-Blatter MF; Haedo MR; Labeur M; Schmid HA; Stalla GK; Arzt E
    Neuroendocrinology; 2011; 94(2):124-36. PubMed ID: 21525729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct effect of cortistatin on GH release from cultured pituitary cells in the rat.
    Baranowska B; Chmielowska M; Wolinska-Witort E; Bik W; Baranowska-Bik A; Martynska L
    Neuro Endocrinol Lett; 2006; 27(1-2):153-6. PubMed ID: 16648801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery.
    Dökmetaş HS; Colak R; Keleştimur F; Selçuklu A; Unlühizarci K; Bayram F
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatostatin, cortistatin and their receptors in tumours.
    Volante M; Rosas R; Allìa E; Granata R; Baragli A; Muccioli G; Papotti M
    Mol Cell Endocrinol; 2008 May; 286(1-2):219-29. PubMed ID: 18248880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
    Boscaro M; Ludlam WH; Atkinson B; Glusman JE; Petersenn S; Reincke M; Snyder P; Tabarin A; Biller BM; Findling J; Melmed S; Darby CH; Hu K; Wang Y; Freda PU; Grossman AB; Frohman LA; Bertherat J
    J Clin Endocrinol Metab; 2009 Jan; 94(1):115-22. PubMed ID: 18957506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Cushing's disease: a mechanistic update.
    Cuevas-Ramos D; Fleseriu M
    J Endocrinol; 2014 Nov; 223(2):R19-39. PubMed ID: 25134660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 12-month phase 3 study of pasireotide in Cushing's disease.
    Colao A; Petersenn S; Newell-Price J; Findling JW; Gu F; Maldonado M; Schoenherr U; Mills D; Salgado LR; Biller BM;
    N Engl J Med; 2012 Mar; 366(10):914-24. PubMed ID: 22397653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
    Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
    Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
    Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary tumours: the sst/D2 receptors as molecular targets.
    Hofland LJ; Feelders RA; de Herder WW; Lamberts SW
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):89-98. PubMed ID: 20438803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.